Cargando…

Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups

Detalles Bibliográficos
Autores principales: Gagez, A-L, Tuaillon, E, Cezar, R, Dartigeas, C, Mahé, B, Letestu, R, Maisonneuve, H, Gouilleux-Gruart, V, Bollore, K, Ferrant, E, Aurran, T, Feugier, P, Leprêtre, S, Cartron, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742632/
https://www.ncbi.nlm.nih.gov/pubmed/26800078
http://dx.doi.org/10.1038/bcj.2015.115
_version_ 1782414229213544448
author Gagez, A-L
Tuaillon, E
Cezar, R
Dartigeas, C
Mahé, B
Letestu, R
Maisonneuve, H
Gouilleux-Gruart, V
Bollore, K
Ferrant, E
Aurran, T
Feugier, P
Leprêtre, S
Cartron, G
author_facet Gagez, A-L
Tuaillon, E
Cezar, R
Dartigeas, C
Mahé, B
Letestu, R
Maisonneuve, H
Gouilleux-Gruart, V
Bollore, K
Ferrant, E
Aurran, T
Feugier, P
Leprêtre, S
Cartron, G
author_sort Gagez, A-L
collection PubMed
description
format Online
Article
Text
id pubmed-4742632
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47426322016-02-22 Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups Gagez, A-L Tuaillon, E Cezar, R Dartigeas, C Mahé, B Letestu, R Maisonneuve, H Gouilleux-Gruart, V Bollore, K Ferrant, E Aurran, T Feugier, P Leprêtre, S Cartron, G Blood Cancer J Letter to the Editor Nature Publishing Group 2016-01 2016-01-22 /pmc/articles/PMC4742632/ /pubmed/26800078 http://dx.doi.org/10.1038/bcj.2015.115 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Gagez, A-L
Tuaillon, E
Cezar, R
Dartigeas, C
Mahé, B
Letestu, R
Maisonneuve, H
Gouilleux-Gruart, V
Bollore, K
Ferrant, E
Aurran, T
Feugier, P
Leprêtre, S
Cartron, G
Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups
title Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups
title_full Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups
title_fullStr Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups
title_full_unstemmed Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups
title_short Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups
title_sort response to rituximab in b-cll patients is adversely impacted by frequency of il-10 competent b cells and fcγriiia polymorphism. a study of fcgcll/wm and goelams groups
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742632/
https://www.ncbi.nlm.nih.gov/pubmed/26800078
http://dx.doi.org/10.1038/bcj.2015.115
work_keys_str_mv AT gagezal responsetorituximabinbcllpatientsisadverselyimpactedbyfrequencyofil10competentbcellsandfcgriiiapolymorphismastudyoffcgcllwmandgoelamsgroups
AT tuaillone responsetorituximabinbcllpatientsisadverselyimpactedbyfrequencyofil10competentbcellsandfcgriiiapolymorphismastudyoffcgcllwmandgoelamsgroups
AT cezarr responsetorituximabinbcllpatientsisadverselyimpactedbyfrequencyofil10competentbcellsandfcgriiiapolymorphismastudyoffcgcllwmandgoelamsgroups
AT dartigeasc responsetorituximabinbcllpatientsisadverselyimpactedbyfrequencyofil10competentbcellsandfcgriiiapolymorphismastudyoffcgcllwmandgoelamsgroups
AT maheb responsetorituximabinbcllpatientsisadverselyimpactedbyfrequencyofil10competentbcellsandfcgriiiapolymorphismastudyoffcgcllwmandgoelamsgroups
AT letestur responsetorituximabinbcllpatientsisadverselyimpactedbyfrequencyofil10competentbcellsandfcgriiiapolymorphismastudyoffcgcllwmandgoelamsgroups
AT maisonneuveh responsetorituximabinbcllpatientsisadverselyimpactedbyfrequencyofil10competentbcellsandfcgriiiapolymorphismastudyoffcgcllwmandgoelamsgroups
AT gouilleuxgruartv responsetorituximabinbcllpatientsisadverselyimpactedbyfrequencyofil10competentbcellsandfcgriiiapolymorphismastudyoffcgcllwmandgoelamsgroups
AT bollorek responsetorituximabinbcllpatientsisadverselyimpactedbyfrequencyofil10competentbcellsandfcgriiiapolymorphismastudyoffcgcllwmandgoelamsgroups
AT ferrante responsetorituximabinbcllpatientsisadverselyimpactedbyfrequencyofil10competentbcellsandfcgriiiapolymorphismastudyoffcgcllwmandgoelamsgroups
AT aurrant responsetorituximabinbcllpatientsisadverselyimpactedbyfrequencyofil10competentbcellsandfcgriiiapolymorphismastudyoffcgcllwmandgoelamsgroups
AT feugierp responsetorituximabinbcllpatientsisadverselyimpactedbyfrequencyofil10competentbcellsandfcgriiiapolymorphismastudyoffcgcllwmandgoelamsgroups
AT lepretres responsetorituximabinbcllpatientsisadverselyimpactedbyfrequencyofil10competentbcellsandfcgriiiapolymorphismastudyoffcgcllwmandgoelamsgroups
AT cartrong responsetorituximabinbcllpatientsisadverselyimpactedbyfrequencyofil10competentbcellsandfcgriiiapolymorphismastudyoffcgcllwmandgoelamsgroups